Showing results (2101-2110 of 2,636) with videos related to
Sort By:
Pageof 264
Journal of Oncology|October 24, 2022
Identification and Development of an Age-Related Classification and Signature to Predict Prognosis and Immune Landscape in OsteosarcomaJinjiong Hong, Xiaofeng Wang, Liang Yu, et al.Journal of Oncology|October 25, 2022
Identification of Key Genes in the HBV-Related HCC Immune Microenvironment Using Integrated Bioinformatics AnalysisWei Ding, Zheng Zhang, Nianyuan Ye, et al.Journal of Oncology|November 4, 2022
The Value of the 8th Edition of American Joint Committee on Cancer Pathological Prognostic Staging on the Selection of Postmastectomy Radiotherapy for T1-2N1 Breast CancerJun Wang, Xiao-Rong Zhong, Ting Luo, et al.Journal of Oncology|November 1, 2022
A-Kinase Anchoring Protein 9 Promotes Gastric Cancer Progression as a Downstream Effector of Cadherin 1Qiang Yan, Youliang Wu, Deguan Li, et al.Journal of Oncology|October 27, 2022
Cancer Progression Mediated by CAFs Relating to HCC and Identification of Genetic Characteristics Influencing PrognosisLi Song, Qiankun Li, Yao Lu, et al.Journal of Oncology|October 27, 2022
Cellular Landscaping of COVID-19 and Gynaecological Cancers: An Infrequent CorrelationRahul Bhattacharjee, Debanjan Das, Radheka Bhadhuri, et al.Journal of Oncology|October 28, 2022
TRPV1 Is a Potential Tumor Suppressor for Its Negative Association with Tumor Proliferation and Positive Association with Antitumor Immune Responses in Pan-CancerRongfang Nie, Qian Liu, Xiaosheng WangJournal of Oncology|October 28, 2022
Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical CancerYujing Shi, Qing Gao, Zeyuan Liu, et al.Journal of Oncology|October 26, 2022
Exploration of Site-Specific Drug Targeting-A Review on EPR-, Stimuli-, Chemical-, and Receptor-Based Approaches as Potential Drug Targeting Methods in Cancer TreatmentMd Shamiul Islam Rasel, Farhana Afrin Mohona, Wahida Akter, et al.Journal of Oncology|October 26, 2022
Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung AdenocarcinomaHui Zhang, Jin Yuan, Yuehua Xiang, et al.Pageof 264